What is incidental prostate cancer?
Incidental prostate cancer refers to a tumor condition discovered after surgical removal of benign prostatic hyperplasia (BPH) in patients without clinical symptoms. The detailed analysis is as follows:
Incidental prostate cancer commonly occurs in patients with benign prostatic hyperplasia and is primarily associated with age. As men age, the level of androgens in the body gradually decreases, leading to reduced stimulation of the prostate gland. This may result in abnormal proliferation of prostate cells and the development of benign prostatic hyperplasia. If, during the course of the disease, patients have unhealthy lifestyle habits or recurrent infections in the prostate area, local cells may undergo malignant transformation, potentially leading to incidental prostate cancer. Typically, these patients do not exhibit any clinical symptoms, and imaging examinations show no abnormalities. The diagnosis is usually confirmed postoperatively when pathological examination of the resected hyperplastic tissue reveals the presence of tumor cells. This condition is considered an early-stage tumor, and complete removal of the lesion via surgery, followed by targeted treatment under medical guidance, can generally achieve clinical cure.
It is recommended to maintain a healthy diet, avoid smoking and alcohol, and pay attention to urination patterns in daily life. If abnormal symptoms such as hematuria (blood in urine) or frequent urination occur, prompt medical evaluation at a hospital is advised.